|
|
 |
|
 |



 |
Welcome.
Bristol-Myers
Squibb places tremendous value on our partnerships. Together with
our partners, we are focused on augmenting and strengthening our
discovery and development potential -- and our pipeline. That is
why everything you will see in this section of our website reflects
our commitment to making partnerships successful.
Bristol-Myers Squibb's licensing process is designed for optimum
communication and fast decisions. After a deal is signed, we leverage
our world-class development organization and global commercialization
infrastructure to create significant value across the entire product
life cycle. All along, our Alliance Management team focuses on the
asset and the relationship with our partners, ensures joint and
transparent decision making and facilitates conflict resolution.
The living proof of our efforts is in more than 190 collaborations
with nearly 130 companies and research institutions, a heritage
of partnering success, including four blockbuster products, and
a range of partnerships that have consistently represented more
than half our global revenues. We see collaborations and partnerships
as one of the key pillars of our success.
We hope you will take time to get to know us through this website.
Please contact us with questions or to submit your opportunity
using
the following link: Submit
Your Opportunity.
Sincerely, The Corporate and Business Development Team
|
|
|
[Top Page] [Search]
[Index] [Contact] [Home]
Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.
© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy. |
|
|
|